Caption Management, LLC Lantheus Holdings, Inc. Call Options Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$58.87 - $83.05 $6.96 Million - $9.82 Million	-118,200 Reduced 51.39%	111,800 $8.98 Million
Q1 2024 May 15, 2024	BUY	$51.07 - $68.26 $10.5 Million - $14 Million	205,000 Added 820.0%	230,000 $14.3 Million
Q4 2023 Feb 14, 2024	BUY	$55.6 - $77.89 $1.39 Million - $1.95 Million	25,000 New	25,000 $1.55 Million
Q4 2022 Feb 14, 2023	SELL	$48.76 - $77.67 $4.14 Million - $6.6 Million	-85,000 Reduced 68.0%	40,000 $2.04 Million
Q3 2022 Nov 14, 2022	BUY	$61.42 - $86.29 $7.68 Million - $10.8 Million	125,000 New	125,000 $8.79 Million

540

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.